Legal & General Group PLC Vertex Pharmaceuticals Inc Transaction History
Legal & General Group PLC
- $368 Billion
- Q4 2024
A detailed history of Legal & General Group PLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Legal & General Group PLC holds 1,884,153 shares of VRTX stock, worth $865 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
1,884,153
Previous 2,303,797
18.22%
Holding current value
$865 Million
Previous $1.07 Billion
29.18%
% of portfolio
0.21%
Previous 0.23%
Shares
29 transactions
Others Institutions Holding VRTX
# of Institutions
1,745Shares Held
227MCall Options Held
1.53MPut Options Held
1.4M-
Capital World Investors Los Angeles, CA28.3MShares$13 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$10.7 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.78 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.5 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$4.79 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $118B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...